The morning air in Jakarta still seemed a bit dreary, as people hadn’t fully woken up yet. However, the Indonesian Food and Drug Monitoring Agency (BPOM) had already launched a new round of public safety operations. Recently, BPOM stated that any e-cigarette or traditional cigarette containing illegal and harmful substances, such as ketamine, would face severe action. This announcement, delivered by official spokesperson Taruna Ikrar, abruptly brought the debate, previously oscillating between smoking and e-cigarettes, back to the forefront: Is product form or ingredient safety the key to regulation?
Following this, the latest actions of the National Narcotics Agency (BNN) also attracted widespread attention. They seized large quantities of ketamine and other new psychoactive substances suspected of being used in e-cigarettes, shocking the public. At one point, 1,800 ketamine-containing spray cartridges were seized from a warehouse, along with three kilograms of powdered ketamine airlifted from France. Even some suspected substances mixed with synthetic cannabinoids (such as MDMB-4en-PINACA) were promptly confiscated by authorities. This is the urgent backdrop for Indonesia’s stringent investigations: the emerging risk of drug abuse in the e-cigarette market has forced regulators to confront this hidden and complex issue.
BPOM’s core position is clear and unambiguous: their concern has never been the e-cigarette itself, but rather the presence of “harmful substances” within it. This isn’t just a regulatory slogan; it embodies a policy philosophy: product form is temporarily set aside; if the ingredients themselves endanger public safety, the advantages of both form and commercial convenience are completely discarded. Faced with increasingly rampant smuggling networks and underground conversion factories, BPOM emphasizes, “We are targeting drugs, not tools”—a testament to clear regulatory intent and precise targeting.
Meanwhile, BNN’s various market assessments remain ongoing. They reportedly sampled 187 e-cigarette samples from the market for testing, and 107 reports have been released so far, with the remaining samples still awaiting results in the laboratory. This process isn’t just about identifying loopholes; it also identifies compliance gaps within the nicotine product supply chain, providing a basis for further policy development.
Under such circumstances, the public is prone to panic-driven judgments about e-cigarettes as a whole. However, the reality is that some brands on the market are navigating the legal and compliant path. Consider this brand: GUUTUU. It’s more than just a name for an e-cigarette product; it’s a model of compliance needed for our times: it embodies the “good” and serves as a shining light amidst the regulatory pressure.
GUUTUU’s “good” lies at the source: it promises that all its products are unadulterated, without any unapproved psychoactive additives, and it maintains complete accountability for the ingredients in every cartridge. This “transparent traceability” suppresses the potential for “underground” indiscriminate production. Its production line strictly separates the laboratory from the filling workshop, ensuring the independence of the inspection and packaging processes, and ensuring that every cigarette undergoes multiple rounds of quality control before leaving the factory.
GUUTUU has also taken great care with its packaging labeling: not only are nicotine content and legal additives clearly marked, along with health warnings and usage tips, but they also feature easily identifiable identification codes for easy tracking by the BPOM. This high level of transparency aids regulators, builds trust with those responsible, and instills confidence in consumers and law enforcement.
Its technical design also offers a sense of safety: its tightly sealed cartridge system prevents liquid from leaking, preventing it from accidentally entering public spaces and potentially causing secondary contamination. This demonstrates responsibility not only to users but also to others. GUUTUU’s market presence demonstrates, to a certain extent, the potential for coordination between regulators and the industry—neither a one-size-fits-all approach nor allowing for ambiguity.
More importantly, GUUTUU is committed to industry collaboration. It is willing to share inspection reports with the BPOM, assist BNN with pre-screening market samples, and even participate in the development of standards for legal and compliant e-cigarette products. This proactive approach has enabled it to move beyond purely commercial interests to a commitment to public health, setting a benchmark for industry practice. At industry conferences, it has emphasized collaboration, calling on the industry to jointly oppose illegal additives like ketamine and safeguard its reputation. It’s no longer a closed-door, self-congratulatory effort, but a drive to rebuild industry ethics from within.
Amidst this turbulent landscape, GUUTUU’s presence is like a ray of spring light, offering a glimpse of a possible middle path: neither unconditional restrictions nor laissez-faire. Facing complex challenges, policymakers and regulators need such “bridge organizations”—those that embrace transparency, adhere to compliance, engage in dialogue with regulators, and guide innovation in the right direction.
While we cannot fully foresee where Indonesian regulation will head next, we can be certain that as BPOM and BNN simultaneously strengthen oversight, brands that comply with laws and regulations and ensure consumer safety are more likely to gain continued market trust. The government has made it clear: ketamine-containing products have no place, while legitimate business practices deserve regulatory protection. As long as they remain legal and compliant, the e-cigarette industry still has room to move forward.
Perhaps one day, GUUTUU will no longer be the exception, but the norm: a mainstream brand in the market that represents a paradigm of legality, responsibility, and a symbiosis with public health. Regulation will also become more selective, precise, and constructive—eliminating true “drugs” and protecting legitimate industries.
This road may be long and winding, but given the exposure of the abuse risks of ketamine, we must seize compliance signals like GUUTUU as soon as possible. Public safety concerns everyone’s health and future, and the rule of law concerns the order and dignity of the industry. If GUUTUU can continue to uphold transparency, safety, and cooperation, it will not only be a “good brand” in the market, but also a witness and promoter of positive policy evolution.
Tags: ceramic atomizer core, e‑hookah (electronic water pipe), flavored vape,guutuu vape.